Friday, September 19, 2008

PDGFs in Non-small Cell Lung Cancer Tumor and Stromal Cells

Serving Cancer and Tumorigenesis Researhers is a central component to our business strategy. This means constantly building our catalog of Cancer Antibodies and Cancer Proteins.

I personally follow up with every customer that purchases our Cancer Research Reagents. This ensures they work as expected. In most cases, this is validate. If not, we fix the expressed issues.

We are now seeing more confirmation by the reagents being referenced in publications. In this publication, our PDGF-C antibody was used as a marker for Non-small Cell Lung Cancer Tumors.

"In univariate analyses, high tumor cell expression of PDGF-B (p  0.001), PDGF-C (p  0.01), and PDGFR- (p  0.026) were negative prognostic indicators for disease-specific survival."

Donnem, Tom MD, Al-Saad, Samer MD, Al-Shibli, Khalid MD, Andersen, Sigve MD, Busund, Lill-Tove MD, PhD, Bremnes, Roy M. MD, PhD. Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells. Journal of Thoracic Oncology. 3(9):963-970, September 2008.

Featured Reagent:

Related Reagents to Consider:
PDGF R Alpha
Cancer Antibodies
All Neurotrophin and Growth Factor Antibodies
Platelet Derived Growth Factor Proteins
Cancer Research Proteins
Neurotrophin and Growth Factor Proteins

No comments: